ACHE and early-onset autosomal dominant Alzheimer disease: Most patients with mild cognitive impairment due to Alzheimer’s disease were treated with nootropics and/or acetylcholinesterase inhibitors (Korea, 96 %; all other regions, 69 %), and almost all were recommended a non-pharmacological treatment (Korea, 93 %; all other regions, 100 %).